98-50-0 Usage
Uses
Used in Animal Feed Industry:
4-Aminophenylarsonic acid is used as an additive in animal feed for its potential growth-promoting effects. However, its use has been restricted or banned in many countries due to its toxic nature.
Used in Veterinary Medicine:
In the past, 4-Aminophenylarsonic acid was used for treating dysentery in swine. Its chemotherapeutic activity made it a potential candidate for treating certain infections in animals.
Used in Chemical Analysis:
4-Aminophenylarsonic acid has been utilized as a reagent in the determination of zirconium, providing more accurate results in the presence of relatively large amounts of accompanying ions compared to phenylarsonic acid. However, this statement has not yet been confirmed.
Used in Pharmaceutical Industry:
4-Aminophenylarsonic acid is used in the manufacture of medicinal arsenicals, contributing to the development of drugs with chemotherapeutic properties.
Originator
Arsanilic acid,Fleming Laboratories, Inc.
Manufacturing Process
342.0 g (2 mol) of 83% arsenic acid were added during 75 min to a rapidly
stirred mixture of 372.5 g (4 mol) aniline and 111.0 g chlorobenzene while
the temperature of the mixture was kept at 147°-150°C. After the addition of
arsenic acid was complete the mixture was stirred for an additional 8 h while
being maintained at 149°-153°C. Water was continuously removed by
distillation, and the organic phase of the distillate was continuously recycled back into the reaction mixture. At the end of that time a total of 121.0 g of
water, containing the condensation of aniline and arsenic acid has been
removed. The mixture was then allowed to cool to 110°C. 562.0 g (2.81 mol)
of 20% sodium hydroxide were added over a 2 h period while water,
chlorobenzene and excess aniline were distilled off at a temperature of from
102°-113°C. The distillation was continued for an additional 2 h while the
volume of the mixture was kept at about 700 ml by the addition of water.
The mixture was then diluted with water to a volume of 1400 ml and allowed
to cool to 23°C. At this point, 52.0 g of by-product material, which was
predominantly tri-(p-aminophenyl)-arsineoxide, were filtered out. The pH of
the filtrate was then brought from 8.7 to 5.1 by the addition of 1.8 mol of
hydrochloric acid while the volume of the mixture was increased to 2,200 ml
by the addition of water. The mixture was stirred for 5 h at room temperature
and again filtered. 108.0 g of by-product material comprising predominantly
di-(p-aminophenyl)-arsinic acid was filtered off at this point.
The pH of the filtrate was lowered to 4.5 by the addition of 0.2 mole of
hydrochloric acid, and an additional 5.0 g of by-products, the composition of
which was not determined, was filtered off. The filtrate was then brought to a
pH of 3.2 by addition of 0.6 mole of hydrochloric acid, and 128.0 g (29.5%
based upon arsenic acid) of arsanilic acid were recovered as a precipitate.
The arsanilic acid filtrate was combined with the by-products filtered off during
each of the three filtration steps. 2.8 mol of hydrochloric acid were added to
the combined arsanilic acid filtrate and the mixture was heated at 80°C for 5
days. Arsanilic acid was then precipitated from the remaining hydrolyzed
mixture in the manner described for the primary reaction product, and an
additional 120.0 g (27.5% based on arsenic acid) were recovered. The filtrate
contained 14.0 g (3.2%) of arsanilic acid which could be recovered at least
partially in subsequent processing. Thus it can be seen from this example that
an arsanilic acid yield of 59% was obtained.
Therapeutic Function
Antibacterial
Hazard
Toxic.
Health Hazard
Occupational workers exposed to p-arsanilic acid develop poisoning. The symptoms
include, but are not limited to, eye and skin irritation, chemical conjunctivitis and corneal
damage, hyperpigmentation of the skin and, perkeratoses of plantar and palmar surfaces,
primary irritation and sensitization, digestive tract irritation, gastrointestinal hypermotility, diarrhea, hepatitis, hepatocellular necrosis, central nervous system depression, cardiac
disturbances, and liver and kidney damage. The target organs include the kidneys, central
nervous system, liver, and cardiovascular system. After a prolonged period of exposure
to arsenic compounds, including arsenical dust, workers are known to develop shortness
of breath, nausea, chest pains, garlic odor, and impairment of peripheral circulation. The
toxicological properties of p-arsanilic acid have not been fully investigated.
Safety Profile
Poison by intravenous
and intraperitoneal routes. Moderately toxic
by ingestion. Flammable, decomposes with heat to yield flammable vapors. When
heated to decomposition or on contact with
acid or acid fumes it emits highly toxic
fumes of As and NO,. See also ARSENIC
COMPOUNDS and ANILINE.
storage
p-Arsanilic acid should be kept stored in a tightly closed container in a cool, dry, wellventilated area. It should be kept away from incompatible materials, dust generation,
excess heat, and strong oxidants.
Purification Methods
Crystallise it from water or ethanol/ether. POISONOUS. [Beilstein 16 I 466.]
Precautions
Occupational workers should wash thoroughly after using p-arsanilic acid. Any contaminated clothing should be washed before reuse. Work areas should have adequate ventilation and minimum dust generation and accumulation. Workers should avoid any
kind of contact of p-arsanilic acid with the eyes, skin, clothing, ingestion or inhalation.
Check Digit Verification of cas no
The CAS Registry Mumber 98-50-0 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 9 and 8 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 98-50:
(4*9)+(3*8)+(2*5)+(1*0)=70
70 % 10 = 0
So 98-50-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H8AsNO3/c8-6-3-1-5(2-4-6)7(9,10)11/h1-4H,8H2,(H2,9,10,11)
98-50-0Relevant academic research and scientific papers
Process for formulating a synthetic drug for use in animal feed, and resulting formulation
-
, (2008/06/13)
A method of formulating a synthetic drug for use in animal feed, for the purpose of reducing carry-over of the synthetic drug to subsequent lots of animal feed in the feed mill.